News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
398,988 Results
Type
Article (27088)
Company Profile (108)
Press Release (371792)
Multimedia
Podcasts (42)
Webinars (9)
Section
Business (102038)
Career Advice (539)
Deals (17994)
Drug Delivery (82)
Drug Development (38776)
Employer Resources (79)
FDA (10757)
Job Trends (9994)
News (175432)
Policy (20689)
Tag
Academia (2117)
Academic (2)
Accelerated approval (2)
Adcomms (12)
Allergies (57)
Alliances (28592)
ALS (46)
Alzheimer's disease (919)
Antibody-drug conjugate (ADC) (60)
Approvals (10811)
Artificial intelligence (211)
Autoimmune disease (14)
Automation (9)
Bankruptcy (148)
Best Places to Work (9004)
BIOSECURE Act (8)
Biosimilars (82)
Biotechnology (60)
Bladder cancer (47)
Brain cancer (13)
Breast cancer (170)
Cancer (1209)
Cardiovascular disease (128)
Career advice (494)
Career pathing (10)
CAR-T (56)
Cell therapy (208)
Cervical cancer (14)
Clinical research (32066)
Collaboration (530)
Compensation (67)
Complete response letters (5)
COVID-19 (2196)
CRISPR (26)
C-suite (147)
Cystic fibrosis (60)
Data (1424)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (186)
Diagnostics (4914)
Digital health (18)
Diversity (6)
Diversity, equity & inclusion (23)
Drug discovery (72)
Drug pricing (98)
Drug shortages (10)
Duchenne muscular dystrophy (55)
Earnings (34413)
Editorial (27)
Employer branding (8)
Employer resources (70)
Events (73080)
Executive appointments (501)
FDA (11724)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (547)
Gene editing (53)
Generative AI (21)
Gene therapy (161)
GLP-1 (429)
Government (4165)
Grass and pollen (4)
Guidances (116)
Healthcare (15029)
Huntington's disease (10)
IgA nephropathy (17)
Immunology and inflammation (57)
Indications (19)
Infectious disease (2329)
Inflammatory bowel disease (96)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (46)
Interviews (58)
IPO (7736)
IRA (35)
Job creations (1408)
Job search strategy (448)
Kidney cancer (4)
Labor market (18)
Layoffs (182)
Leadership (5)
Legal (3912)
Liver cancer (44)
Lung cancer (162)
Lymphoma (80)
Machine learning (6)
Management (30)
Manufacturing (174)
MASH (47)
Medical device (9383)
Medtech (9386)
Mergers & acquisitions (10624)
Metabolic disorders (479)
Multiple sclerosis (54)
NASH (10)
Neurodegenerative disease (47)
Neuropsychiatric disorders (16)
Neuroscience (1248)
NextGen: Class of 2025 (4983)
Non-profit (3930)
Now hiring (7)
Obesity (258)
Opinion (121)
Ovarian cancer (35)
Pain (50)
Pancreatic cancer (32)
Parkinson's disease (80)
Partnered (13)
Patents (110)
Patient recruitment (74)
Peanut (30)
People (32719)
Pharmaceutical (32)
Pharmacy benefit managers (18)
Phase I (10205)
Phase II (12587)
Phase III (11410)
Pipeline (836)
Policy (121)
Postmarket research (1573)
Preclinical (3259)
Press Release (47)
Prostate cancer (63)
Psychedelics (23)
Radiopharmaceuticals (150)
Rare diseases (254)
Real estate (2842)
Recruiting (31)
Regulatory (14122)
Reports (21)
Research institute (1913)
Resumes & cover letters (40)
Rett syndrome (3)
RNA editing (3)
RSV (35)
Schizophrenia (47)
Series A (87)
Series B (66)
Service/supplier (4)
Sickle cell disease (50)
Special edition (10)
Spinal muscular atrophy (87)
Sponsored (18)
Startups (2091)
Stomach cancer (3)
Supply chain (47)
Tariffs (27)
The Weekly (24)
Vaccines (576)
Venture capitalists (26)
Weight loss (148)
Women's health (33)
Worklife (6)
Date
Last 7 days (559)
Last 30 days (1688)
Last 365 days (20368)
2025 (7500)
2024 (21779)
2023 (24258)
2022 (33687)
2021 (37126)
2020 (37569)
2019 (33252)
2018 (24878)
2017 (17708)
2016 (18859)
2015 (21430)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13905)
2010 (11929)
Location
Africa (515)
Alabama (26)
Alaska (6)
Arizona (124)
Arkansas (11)
Asia (21557)
Australia (3858)
California (3523)
Canada (1357)
China (313)
Colorado (177)
Connecticut (206)
Delaware (83)
Europe (48271)
Florida (581)
Georgia (166)
Hawaii (1)
Idaho (35)
Illinois (378)
India (22)
Indiana (283)
Iowa (7)
Japan (121)
Kansas (80)
Kentucky (17)
Louisiana (11)
Maine (66)
Maryland (649)
Massachusetts (2738)
Michigan (151)
Minnesota (240)
Mississippi (2)
Missouri (82)
Montana (16)
Nebraska (19)
Nevada (52)
New Hampshire (51)
New Jersey (1282)
New Mexico (11)
New York (1172)
North Carolina (672)
North Dakota (3)
Northern California (1587)
Ohio (134)
Oklahoma (9)
Oregon (23)
Pennsylvania (928)
Puerto Rico (7)
Rhode Island (20)
South America (675)
South Carolina (15)
South Dakota (1)
Southern California (1300)
Tennessee (90)
Texas (498)
United States (14857)
Utah (156)
Virginia (91)
Washington D.C. (46)
Washington State (384)
West Virginia (3)
Wisconsin (52)
398,988 Results for "elysium health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Elysium Therapeutics Announces Compelling Human Proof-of-Concept Data for its SMART™ Opioid, O2P™ Hydrocodone Prodrug for Acute Pain that Could Disrupt the Industry by Establishing New Standards for Opioid Safety
Elysium Therapeutics today announced positive results from a Phase 1, human-proof-of-concept study (O2P-001) investigating the company’s proprietary Oral Overdose Protected (O2P™) hydrocodone prodrug for the treatment of moderate-to-severe acute pain.
March 5, 2024
·
7 min read
Pharm Country
Elysium Health™ Announces Positive Results on Its Product Basis™ Published in Hepatology
Elysium Health, Inc.™, a leading life sciences company focused on aging research, today announced that the detailed results from its clinical trial on Basis™ (NRPT) in people with non-alcoholic fatty liver disease (NAFLD) were published in Hepatology.
October 12, 2022
·
4 min read
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Press Releases
Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month
May 2, 2025
·
8 min read
Press Releases
Bausch Health Announces Health Canada Clearance of Solta Medical’s Thermage(R) FLX System
April 30, 2025
·
4 min read
Pharm Country
Elysium Health™ Announces Research Partnership with the University of Oxford for the Purpose of Developing Epigenetic Measures of Brain Aging and Health
Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into a material transfer agreement with the University of Oxford to examine hundreds of samples from the VITACOG study to develop epigenetic measures of brain aging and health.
March 23, 2022
·
4 min read
Business
Elysium Health™ Announces New Research Initiative in Partnership With the University of Oxford in Connection With the Landmark INTERBIO-21st Study
Elysium Health, Inc. has entered into a material transfer agreement with the University of Oxford to analyze the DNA methylation patterns of 2,500 umbilical cord blood samples from the landmark INTERBIO-21st Study.
April 6, 2022
·
4 min read
1 of 39,899
Next
